Quick Answer
A tesamorelin ipamorelin blend is a GH-axis research blend. Tesamorelin is a GHRH analog with strong clinical evidence for reducing visceral abdominal fat. Ipamorelin is a ghrelin-receptor agonist and GH secretagogue. Some research listings also add CJC-1295, another GHRH analog, creating a broader GH-signaling blend.
The important distinction is evidence. Tesamorelin itself has the strongest direct data for visceral fat. The blend idea is mostly mechanistic: combine related GH-axis signals and study the response. That can be interesting, but it is not the same as saying the exact blend has the same clinical proof as tesamorelin alone.
Explore the AminoRank tesamorelin profileReview linked studies, category details, and vendor availability for tesamorelin.View tesamorelin profileWhy This Blend Exists
The blend exists because tesamorelin and ipamorelin approach GH signaling from different angles. Tesamorelin works through growth-hormone-releasing hormone signaling. Ipamorelin works through the ghrelin/growth-hormone secretagogue receptor pathway.
That makes the pairing easy to understand: one peptide is on the GHRH side, the other is on the secretagogue side. In theory, that can create a stronger or broader GH pulse than either category alone. In practice, the exact blend still needs to be judged more cautiously than tesamorelin's published visceral-fat studies.
The Evidence Hierarchy
Tesamorelin has the best clinical support in this cluster. In the major randomized trial, tesamorelin reduced visceral adipose tissue by 10.9% over six months compared with 0.6% with placebo. Longer data showed sustained VAT reduction during continued treatment.
Ipamorelin has published GH-secretagogue and clinical research, but not the same visceral-fat evidence. In a phase 2 postoperative ileus study, ipamorelin was well tolerated but did not significantly improve the key efficacy endpoint versus placebo.
CJC-1295 has human data showing prolonged GH and IGF-1 stimulation, but it is not a direct substitute for tesamorelin's abdominal-fat evidence.
| Component | Best-supported role |
|---|---|
| Tesamorelin | Strongest direct evidence for visceral abdominal-fat reduction. |
| Ipamorelin | GH secretagogue pathway; useful comparator and blend component. |
| CJC-1295 | Long-acting GHRH analog with GH/IGF-1 stimulation data. |
| Full blend | Mechanistically interesting, but less directly proven than tesamorelin alone. |
Tesamorelin Plus Ipamorelin
The cleanest blend logic is tesamorelin plus ipamorelin. Tesamorelin stimulates the GHRH receptor pathway. Ipamorelin stimulates the ghrelin receptor pathway. Readers interested in growth-hormone peptide stacks are usually attracted to this dual-pathway logic.
Still, tesamorelin should remain the anchor. If the goal is visceral fat and waist profile, tesamorelin is the component with the strongest evidence. Ipamorelin adds GH-secretagogue rationale, not a duplicate visceral-fat trial record.
CJC-1295, Ipamorelin, And Tesamorelin 12 Mg Blends
Some vendors list 12 mg blends that combine tesamorelin, CJC-1295 or modified GRF, and ipamorelin. These products attract attention because they look like an all-in-one GH-axis formula.
The risk is that the blend name can sound more proven than it is. Each component has its own evidence profile, but the exact mixed vial is usually not backed by a matching randomized clinical trial. A serious article should say that clearly without dismissing the research interest.
Blend Dosage Context
Blend dosage is more complicated than single-compound dosage because a vial can contain multiple peptides in a fixed ratio. A 12 mg blend does not mean 12 mg of tesamorelin. It means 12 mg total peptide across the blend components, unless the vendor gives a different breakdown.
That makes label reading essential. If a vial contains tesamorelin, ipamorelin, and CJC-1295, the amount of each component matters. Without the ratio, dosage math is incomplete.
Reconstitution Math
Reconstitution math for blends has two layers. First, calculate the total concentration of the vial after adding liquid. Second, understand the per-component amount based on the blend ratio.
For example, if a 12 mg blend is evenly split across three peptides, each peptide contributes 4 mg to the vial. If the split is not even, the math changes. This is why blend labels should be clear and why generic unit charts can mislead readers.
Use the peptide calculatorCalculate concentration and syringe-unit math for research planning.Open calculatorVendor Comparison
Blends deserve an even higher documentation standard than single-compound vials because there are more ways for the listing to be unclear. Look for COA status, product naming, component ratios, reviews, shipping, payment options, country, and promo codes.
Tesamorelin Vendors And Blend Research Listings
View all Tesamorelin vendors| Vendor | Country | Rating | COAs | Promo | Payment | Shipping | Website |
|---|---|---|---|---|---|---|---|
| LA Peptides | USA | 5.0 (1) | Yes | 10% off (AMINORANK) | Card, ACH | Fast shipping, International | Buy |
| NextGenPeps | USA | 5.0 (1) | Yes | 10% off (AMINORANK) | Card, ACH, Crypto | Fast shipping | Buy |
| Alpha Peptides | USA | 0.0 (0) | Yes | 10% off (AMINORANK) | Card | Standard | Buy |
| Ascension Peptides | USA | 0.0 (0) | Yes | 50% off (AMINORANK) | Card | Standard | Buy |
| BioCollex | USA | 0.0 (0) | Yes | 10% off (AMINORANK) | Not listed | International | Buy |
| Coastal Peptides | USA | 0.0 (0) | Yes | None listed | Card | Fast shipping, International | Buy |
| Eternal Peptides | USA | 0.0 (0) | Yes | None listed | Card, ACH, Crypto | Fast shipping | Buy |
| Evolve BioPep | USA | 0.0 (0) | Yes | 5% off (AMINORANK) | Card | Standard | Buy |
FAQ
Is tesamorelin ipamorelin better than tesamorelin alone?
Not necessarily. Tesamorelin alone has the stronger direct visceral-fat evidence. The blend is mechanistically interesting but less directly proven.
What is the point of adding ipamorelin?
Ipamorelin acts through the ghrelin/GH-secretagogue pathway, which is different from tesamorelin's GHRH pathway.
Is a 12 mg blend a 12 mg tesamorelin dose?
No. A 12 mg blend usually means total peptide amount across components, not 12 mg of tesamorelin.
Should blends use a calculator?
Yes, for concentration and syringe-unit math. A calculator does not provide medical dosing advice.